Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 290

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Effect of High-Flow Oxygen Therapy vs Conventional Oxygen Therapy on Invasive Mechanical Ventilation and Clinical Recovery in Patients With Severe COVID-19: A Randomized Clinical Trial

Open access
Ospina-Tascón, Gustavo A., Calderón-Tapia, Luis Eduardo, García, Alberto F., Zarama, Virginia, Gómez-Álvarez, Freddy, Álvarez-Saa, Tatiana, Pardo-Otálvaro, Stephania, Bautista-Rincón, Diego F., Vargas, Mónica P., Aldana-Díaz, José L., Marulanda, Ángela, Gutiérrez, Alejandro, Varón, Janer, Gómez, Mónica, Ochoa, María E., Escobar, Elena, Umaña, Mauricio, Díez, Julio, Tobón, Gabriel J., Albornoz, Ludwig L., Celemín Flórez, Carlos Augusto, Ruiz, Guillermo Ortiz, Cáceres, Eder Leonardo, Reyes, Luis Felipe, Damiani, Lucas Petri, Cavalcanti, Alexandre B., HiFLo-Covid Investigators, Rosso, Fernando, Moncada, Pablo A., Carvajal, Sandra, Yara, Julián, Jiménez, Alejandro, Sotomayor, Alex, Prieto, Maria I., López, Daniel, Medina, Camilo, Ángel, Ana M., Giraldo, Natalia, Watts, Freddy, Morell, Tatiana, Revelo, Jorge, de Paz, David, Villamil, Wilson, Orozco, Nicolás, Rojas, Cristhian C., Martínez, Diana M., Sánchez, Álvaro I., Vallecilla, Liliana, Sandoval, Jenny A., Crispín, Ana M., Carvajal, Katherine, Romero, Liliana, Guarín, Nicol · 2021 · JAMA

Abstract

IMPORTANCE: The effect of high-flow oxygen therapy vs conventional oxygen therapy has not been established in the setting of severe COVID-19. OBJECTIVE: To determine the effect of high-flow oxygen therapy through a nasal cannula compared with conventional oxygen therapy on need for endotracheal intubation and clinical recovery in severe COVID-19. DESIGN, SETTING, AND PARTICIPANTS: Randomized, open-label clinical trial conducted in emergency and intensive care units in 3 hospitals in Colombia. A total of 220 adults with respiratory distress and a ratio of partial pressure of arterial oxygen to fraction of inspired oxygen of less than 200 due to COVID-19 were randomized from August 2020 to January 2021, with last follow-up on February 10, 2021. INTERVENTIONS: Patients were randomly assigned to receive high-flow oxygen through a nasal cannula (n = 109) or conventional oxygen therapy (n = 111). MAIN OUTCOMES AND MEASURES: The co-primary outcomes were need for intubation and time to clinical recovery until day 28 as assessed by a 7-category ordinal scale (range, 1-7, with higher scores indicating a worse condition). Effects of treatments were calculated with a Cox proportional hazards model adjusted for hypoxemia severity, age, and comorbidities. RESULTS: Among 220 randomized patients, 199 were included in the analysis (median age, 60 years; n = 65 women [32.7%]). Intubation occurred in 34 (34.3%) randomized to high-flow oxygen therapy and in 51 (51.0%) randomized to conventional oxygen therapy (hazard ratio, 0.62; 95% CI, 0.39-0.96; P = .03). The median time to clinical recovery within 28 days was 11 (IQR, 9-14) days in patients randomized to high-flow oxygen therapy vs 14 (IQR, 11-19) days in those randomized to conventional oxygen therapy (hazard ratio, 1.39; 95% CI, 1.00-1.92; P = .047). Suspected bacterial pneumonia occurred in 13 patients (13.1%) randomized to high-flow oxygen and in 17 (17.0%) of those randomized to conventional oxygen therapy, while bacteremia was detected in 7 (7.1%) vs 11 (11.0%), respectively. CONCLUSIONS AND RELEVANCE: Among patients with severe COVID-19, use of high-flow oxygen through a nasal cannula significantly decreased need for mechanical ventilation support and time to clinical recovery compared with conventional low-flow oxygen therapy. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04609462.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jama.2021.20714

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 290

Metadata

Authors
Ospina-Tascón, G. A., Calderón-Tapia, L. E., García, A. F., Zarama, V., Gómez-Álvarez, F., Álvarez-Saa, T., Pardo-Otálvaro, S., Bautista-Rincón, D. F., Vargas, M. P., Aldana-Díaz, J. L., Marulanda, Á., Gutiérrez, A., Varón, J., Gómez, M., Ochoa, M. E., Escobar, E., Umaña, M., Díez, J., Tobón, G. J., Albornoz, L. L., Celemín Flórez, C. A., Ruiz, G. O., Cáceres, E. L., Reyes, L. F., Damiani, L. P., Cavalcanti, A. B., HiFLo-Covid Investigators, Rosso, F., Moncada, P. A., Carvajal, S., Yara, J., Jiménez, A., Sotomayor, A., Prieto, M. I., López, D., Medina, C., Ángel, A. M., Giraldo, N., Watts, F., Morell, T., Revelo, J., de Paz, D., Villamil, W., Orozco, N., Rojas, C. C., Martínez, D. M., Sánchez, Á. I., Vallecilla, L., Sandoval, J. A., Crispín, A. M., Carvajal, K., Romero, L., & Guarín, N.
Venue
JAMA
Published
2021-12-07
Volume
326
Issue
21
Pages
2161
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W4200281049
Cited by
290
References
24
FWCI
33.05
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of High-Flow Oxygen Therapy vs Conventional Oxygen Therapy on Invasive Mechanical Ventilation and Clinical Recovery in Patients With Severe COVID-19: A Randomized Clinical Trial. https://app.cochat.ai/papers/10.1001/jama.2021.20714
The paper
Ospina-Tascón, G. A., Calderón-Tapia, L. E., García, A. F., Zarama, V., Gómez-Álvarez, F., Álvarez-Saa, T., Pardo-Otálvaro, S., Bautista-Rincón, D. F., Vargas, M. P., Aldana-Díaz, J. L., Marulanda, Á., Gutiérrez, A., Varón, J., Gómez, M., Ochoa, M. E., Escobar, E., Umaña, M., Díez, J., Tobón, G. J., . . . Guarín, N. (2021). Effect of High-Flow Oxygen Therapy vs Conventional Oxygen Therapy on Invasive Mechanical Ventilation and Clinical Recovery in Patients With Severe COVID-19: A Randomized Clinical Trial. JAMA. https://doi.org/10.1001/jama.2021.20714

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.